Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024, Featuring Sanofi, Bristol Myers Squibb, Abbott Laboratories, Takeda Pharmaceutical and Amgen
March 08, 2024 04:28 ET
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The chemotherapy...
Neuropathix, Inc. Announces Publication of Its Global PCT Patent for NPTX-204, a Novel Hops-Inspired Neuroprotectant
January 19, 2021 09:00 ET
|
Neuropathix, Inc.
DOYLESTOWN, Pa., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (“Neuropathix” or the “Company”) (OTCQB: NPTX), a socially responsible pain management life sciences company, announced the...
Growth in Neuroprotective Agents Market Projected to 2022
June 18, 2018 06:00 ET
|
BCC Research
WELLESLEY, Mass., June 18, 2018 (GLOBE NEWSWIRE) -- Longer life spans, the increasing prevalence of neurological disorders (particularly neurodegenerative diseases), stroke and traumatic central...
Kannalife Sciences Discusses Orphan Drug Opportunity for KLS-13019
August 11, 2015 13:50 ET
|
KannaLife Sciences, Inc.
NEW YORK, Aug. 11, 2015 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc., a Phyto-Medical Company, describes orphan drug opportunity for KLS-13019, a Novel Functionalized 1,3-Benzene Diol for the...
KannaLife Sciences Announces Publication of Its Global PCT Patent Covering Cannabidiol-like Neuroprotective Agents
August 06, 2015 13:54 ET
|
KannaLife Sciences, Inc.
NEW YORK, Aug. 6, 2015 (GLOBE NEWSWIRE) -- KannaLife Sciences, Inc., a Phyto-Medical Company, announced the publication of its global WIPO/PCT Patent WO2015/106108A2 – 'Novel Functionalized...